The ROI invests in research to heighten the critical role of radiation oncology in the treatment of cancer. Requests for Proposals (RFPs) are strategically developed to inspire research that is practical and has the potential to transform cancer management and the therapies that are offered to patients on a daily basis.
The ROI is currently accepting Letters of Intent for the Biomarkers for Radiation Oncology RFP. Propose your best ideas for research that will leverage biomarkers to enhance patient selection, develop personalized treatment regimens, quantify outcomes and manage toxicity. The two-year grants will typically be $50,000, but budgets up to $150,000 will be considered for projects with a larger scope. See the complete RFP for details.
Letters of Intent for the Biomarkers for Radiation Oncology RFP are due November 16, 2020 at 5:00 p.m. Eastern time. The deadline for invited proposals will be in February. All applications must be submitted through ProposalCentral.
The ROI only accepts applications for funding in response to issued RFPs.
Topics for the ROI's previous RFPs include:
- Improving Diversity and Inclusion in Radiation Oncology
- Personalized Radiation Therapy
- Leveraging Big Data to Optimize Quality Assurance and Patient Care Improvement Initiatives
- Safety and Quality: IMRT Treatment Delivery Accuracy
- Best Practices for Toxicity Management in Radiation Oncology
- Examination of the Comparative Value of Radiation Therapy
- Innovative Projects in Radiation Oncology
All Letters of Intent and proposals to the ROI must be submitted through ProposalCentral. After logging in to ProposalCentral, go to the "Grant Opportunities" tab and select "Radiation Oncology Institute" in the "Filter List by GrantMaker" drop-down menu. If you have questions about the ROI's research funding opportunities, please contact us.
You can help support ROI's current research and future awards by donating to the ROI today.